Average Co-Inventor Count = 4.00
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Colorado (8 from 1,381 patents)
2. J-pharma Co., Ltd. (3 from 9 patents)
3. Eastman Chemical Company (2 from 2,002 patents)
4. University of Virginia Patent Foundation (2 from 998 patents)
5. Indiana University (2 from 769 patents)
6. Other (1 from 832,843 patents)
7. National Jewish Health (1 from 88 patents)
14 patents:
1. 12458628 - Cancer therapeutic
2. 12043601 - N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same
3. 12025596 - 6-oxo-pipecolic acid quantitation by mass spectrometry
4. 11964985 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
5. 11472812 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
6. RE48557 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
7. 10689392 - Anti-cancer compounds targeting ral GTPases and methods of using the same
8. 10676480 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
9. 10202397 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
10. 10172835 - Anticancer agent composition
11. 10005750 - Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
12. 9353121 - Anti-cancer compounds targeting Ral GTPases and methods of using the same
13. 8263094 - Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
14. 8183398 - 5-hydroxy-2-methyl-4H-pyran-4-one esters as novel tyrosinase inhibitors